Osaic Holdings
INBX icon

Osaic Holdings’s Inhibrx INBX Stock Holding History

Osaic Holdings’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.39K Buy
78
+8
+11% +$802 ﹤0.01% 6759
2026
Q1 		$4.71K Buy
70
+2
+3% +$148 ﹤0.01% 6712
2025
Q4 		$5.37K Sell
68
-51
-43% -$3.48K ﹤0.01% 6673
2025
Q3 		$4.01K Buy
119
+35
+42% +$862 ﹤0.01% 6870
2025
Q2 		$1.2K Buy
+84
New +$1.09K ﹤0.01% 7094
2025
Q1 		– Sell
-1,751
Closed -$27K – 7580
2024
Q4 		$27K Buy
1,751
+1,666
+1,960% +$25.4K ﹤0.01% 5129
2024
Q3 		$1.33K Buy
85
+5
+6% +$70 ﹤0.01% 6748
2024
Q2 		$1.13K Buy
+80
New +$1.25K ﹤0.01% 6779

Other funds holding INBX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Osaic Holdings's INBX Position: Q2 2026 in Review

Osaic Holdings increased its Inhibrx (INBX) stake by 11% in Q2 2026, buying an estimated $802 and bringing the position to 78 shares worth $7.39K. The position accounts for ﹤0.01% of the portfolio, ranked #6759.

Osaic Holdings first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. The position peaked at $27K in Q4 2024. 162 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Osaic Holdings held 78 shares of Inhibrx worth $7.39K as of Q2 2026.
  • Osaic Holdings bought 8 Inhibrx shares in Q2 2026, an estimated $802.
  • Inhibrx made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #6759 holding.
  • Osaic Holdings first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • Osaic Holdings's Inhibrx position peaked at $27K in Q4 2024.
  • 162 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.